The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Comparison of Glycated Albumin and Hemoglobin A 1c Concentrations in Diabetic Subjects on Peritoneal and Hemodialysis
Abstract
Background Relative to hemoglobin A(1c) (HbA(1c)), percentage of glycated albumin (GA%) more accurately reflects recent glycemic control in diabetic hemodialysis (HD) patients. Methods To determine the accuracy of glycemic assays in a larger sample including patients on peritoneal dialysis (PD), HbA(1c) and GA% were measured in 519 diabetic subjects: 55 on PD, 415 on HD, and 49 non-nephropathy controls. Results Mean +/- SD serum glucose levels were higher in HD and PD patients relative to non-nephropathy controls (HD 169.7 +/- 62 mg/dL, PD 168.6 +/- 66 mg/dL, controls 146.1 +/- 66 mg/dL; p = 0.03 HD vs controls, p = 0.13 PD vs controls). GA% was also higher in HD and PD patients (HD 20.6% +/- 8.0%, PD 19.0% +/- 5.7%, controls 15.7% +/- 7.7%; p Conclusions The relationship between HbA(1c) and GA% differs in diabetic patients with end-stage renal disease who perform either PD or HD compared to those without nephropathy. HbA(1c) significantly underestimates glycemic control in peritoneal and hemodialysis patients relative to GA%.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Correlations of directly measured blood glucose levels with 3 glycemic biomarkers -HbA1c, glycated albumin, and fructosamine -were progressively weaker with advanced CKD stages (G4 -G5), especially kidney failure treated by dialysis. 196,197,205,210,227”
From KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (2022) · cites this paper as [205]
In the citing paper
“Practice Point 2.1.2: Accuracy and precision of HbA1c measurement declines with advanced CKD (G4 -G5), particularly among patients treated by dialysis, in whom HbA1c measurements have low reliability.”
From KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (2022) · cites this paper as [205]
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin
Bry, L., Chen, P. C., & Sacks, D. B. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.2.153 · Cited by 523 · cited 1×
“Although HbS and HbC appear to bind glucose more avidly than HbA and could therefore increase HbA1c levels (12), ethnic differences in GA, HbA1c, and serum glucose relationships among diabetic ESRD patients appear unlikely to be fully explained by carriage of HbS or HbC.”
BackgroundInaba, M., Okuno, S., Kumeda, Y., Yamada, S., Imanishi, Y., Tabata, T., Okamura, M., Okada, S., Yamakawa, T., Ishimura, E., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070772 · Cited by 495
Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis
Peacock, T. P., Shihabi, Z. K., Bleyer, A. J., Dolbare, E. L., Byers, J. R., Knovich, M. A., Calles-Escandon, J., Russell, G. B., & Freedman, B. I. (2008) · Kidney International · doi:10.1038/ki.2008.25 · Cited by 323
Self-citationRed blood cell survival in chronic renal failure
Ly, J., Marticorena, R. M., & Donnelly, S. M. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.06.018 · Cited by 160
Conversion between bromcresol green‐ and bromcresol purple‐measured albumin in renal disease
Clase, C. M., Pierre, M. W. S., & Churchill, D. N. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.9.1925 · Cited by 97
Glycated albumin levels predict long‐term survival in diabetic patients undergoing haemodialysis
Fukuoka, K., Nakao, K., Morimoto, H., NAKAO, A., Takatori, Y., Arimoto, K., Taki, M., Wada, J., & Makino, H. (2007) · Nephrology · doi:10.1111/j.1440-1797.2007.00864.x · Cited by 96
Rubenstein, A. H., Mako, M. E., & Horwitz, D. L. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180518 · Cited by 69
Abe, M., & Matsumoto, K. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph0881 · Cited by 53
Muramoto, Y., Matsushita, M., & Irino, T. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00158-8 · Cited by 49
Cited by
Sorted by citations
Items 101–120 of 120
Клінічна інтерференція при оцінці рівня глікозильованого гемоглобіну. Опис клінічного випадку
Gurzhiy, O. V. (2021) · Endokrynologia · doi:10.31793/1680-1466.2021.26-2.199 · Cited by 1
Nakamura, A., Kodera, R., Sakamoto, N., Ujike, H., Wada, J., Shikata, K., & Makino, H. (2018) · Diabetology International · doi:10.1007/s13340-018-0342-6 · Cited by 1
Selection of aptamers for human serum albumin and its glycated form
Wilkinson, D. (2016) · Spiral (Imperial College London) · doi:10.25560/45288 · Cited by 1
(2014) · Macedonian Journal of Medical Sciences · doi:10.3889/mjms.1857-5773.2014.0398
Raikou, V. D., & Kyriaki, D. (2015) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd2020066
Otieno, C. F., Wandolo, G., Lotodo, T. C., & Sekadde-Kigondu, C. B. (2015)
Glycemic control in patients with diabetes and nephropathy
Freedman, B. I., & Tuttle, A. B. (2012) · JAAPA · doi:10.1097/01720610-201211000-00006
Self-citationFesta, R., Mosca, A., Lapolla, A., Paleari, R., FOTI, D. P., Ferrai, G., & Testa, R. (2012)
Management of Diabetes Mellitus in Acute and Chronic Cardiorenal Syndromes
Hahr, A. J., & Molitch, M. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-57460-4_23
Ramanathan, K., & Padmanabhan, G. (2014) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2014.076
Hahr, A. J., & Molitch, M. E. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0793-9_16
Glycemic control of diabetes dialysis patients and ‘burnt-out diabetes’
Miyasato, K., Takao, N., Maruyama, N., & Abe, M. (2023) · Nihon Toseki Igakkai Zasshi · doi:10.4009/jsdt.56.323
Associations between glycated albumin and current measures of glycaemic control in Saudi adults
Bahijri, S., Sabban, A., Enani, S. M., Alqahtani, M. S., Malibary, M., Alhashmi, M. H., & Tuomileto, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1731945
Hemoglobinvariánsok okozta nehézségek a hemoglobin-A1c értékelése során két eset kapcsán
Derzsi, N., Czégeni, A., Tomasics, G., Konderák, J., Schandl, L., Winkler, G., & Pintér, E. (2026) · Orvosi Hetilap · doi:10.1556/650.2026.33478
Singh, A., Tandon, S., Tandon, C., & Srivastav, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40316-3.00018-7
Zhou, C., Wu, X., Tian, Z., Li, M., Liu, F., & Li, J. (2026) · BMC Geriatrics · doi:10.1186/s12877-026-07560-1
Zhang, H., Yang, J., Shan, X., Pan, M., Ding, J., Ding, G., & Yang, L. (2026) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr50219
Huang, H., Shi, Y. L., Fang, P., Tang, S., Xu, W., Zhou, C., Zhou, Y., Zhang, K., & Xue, Y. (2026) · Renal Failure · doi:10.1080/0886022x.2026.2731649
Aihara, M., & Kubota, N. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70447
Metadata
- Authors
- Freedman, B. I., Shenoy, R. N., Planer, J. A., Clay, K. D., Shihabi, Z. K., Burkart, J. M., Cardona, C. Y., Andries, L., Peacock, T. P., Sabio, H., Byers, J. R., Russell, G. B., & Bleyer, A. J.
- Affiliations
- Wake Forest University Health Sciences (US)
- Venue
- Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis
- Publisher
- SAGE Publications
- Published
- 2010-01
- Volume
- 30
- Issue
- 1
- Pages
- 72-79
- ISSN
- 0896-8608 (ISSN-L)
- 1718-4304
- OpenAlex
- W2126851999
- Cited by
- 121
- References
- 14
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 9 · 2019: 2 · 2018: 5 · 2017: 9 · 2016: 9 · 2015: 13 · 2014: 15 · 2013: 14 · 2012: 13
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Peritoneal Dialysis International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Keywords
- glycated albumin, HbA1c, glycemic control, diabetes mellitus, end-stage renal disease, peritoneal dialysis, hemodialysis, serum glucose, glycemic markers, diabetic nephropathy
- MeSH terms
- Glycated Serum Albumin, Diabetes Mellitus, Female, Renal Dialysis, Glycated Hemoglobin, Humans, Kidney Failure, Chronic, Male, Middle Aged, Peritoneal Dialysis, Serum Albumin, Glycation End Products, Advanced, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
